FDA Should Scrap Manufacturing Changes Proposed Rule, Guidance - PhRMA
Executive Summary
FDA's proposed rule "Supplements and Other Changes to an Approved Application" and its accompanying guidance should be abandoned, the Pharmaceutical Research & Manufacturers of America asserted in Aug. 27 comments to the agency.